These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 5984628)

  • 1. [Apropos of the local use of hemocaprol].
    Spay M
    Sem Ther; 1966; 42(6):384. PubMed ID: 5984628
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the treatment of menometrorrhagia with hemocaprol].
    François S
    Sem Ther; 1965 Jan; 41(1):39. PubMed ID: 5879033
    [No Abstract]   [Full Text] [Related]  

  • 3. [Postoperative hemorrhage in gynecology treated with hemocaprol].
    Malier P
    Sem Ther; 1964 Nov; 40(9):577. PubMed ID: 5878676
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatments of meno-metrorrhagia with hemocaprol (epsilon aminocaproic acid)].
    Malene Y
    Sem Ther; 1964 Oct; 40(8):505. PubMed ID: 5878577
    [No Abstract]   [Full Text] [Related]  

  • 5. [Importance of hemocaprol in O.R.L].
    Vankemmel B
    Sem Ther; 1965 May; 41(5):313. PubMed ID: 5878953
    [No Abstract]   [Full Text] [Related]  

  • 6. [A clinical use of trans amino methyl cyclohexane carboxylic acid in cases of diabetic retinopathy].
    Manabe R; Hoshino T
    Nihon Ganka Kiyo; 1966 Apr; 17(4):466-9. PubMed ID: 4225315
    [No Abstract]   [Full Text] [Related]  

  • 7. [Action of epsilon-aminocaroic acid in intolerance to contrast media containing organic iodine].
    Patoir G; Bonnière B; Devulder G
    Sem Ther; 1968 Dec; 44(10):677-8. PubMed ID: 4303226
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of acute fibrinolysis].
    Larrieu MJ
    Sem Ther; 1963 May; 39(5):353-5. PubMed ID: 5877959
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic use of epsilon aminocaproic acid].
    Josso F
    Sem Ther; 1964 Jan; 40(1):19-21. PubMed ID: 5878904
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fibrinolysis and its treatment].
    Piguet H
    Sem Ther; 1965; 41(6):352-5. PubMed ID: 5879230
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemocaprol and allergic complications of therapeutic origin].
    Baille Y; Monties JR; Goudard A; Blanc T; Henry E
    Mars Med; 1969; 106(7):637-41. PubMed ID: 5399371
    [No Abstract]   [Full Text] [Related]  

  • 12. [Use of aminocaproic acid in certain O.R.L. hemorrhages].
    Albertini F; Léger P
    Sem Ther; 1964 Dec; 40(10):647. PubMed ID: 5879138
    [No Abstract]   [Full Text] [Related]  

  • 13. [Advantageous effects of epsilon aminocaproic acid in a severe non-fibrinolytic hemorrhagic syndrome].
    Lebeaupin R; Guimbretière J; Tendron J; Habert C
    Sem Ther; 1964 Nov; 40(9):564-6. PubMed ID: 5878671
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment with epsilon aminocaproic acid in persistent hematuria after renal punch biopsy].
    Gaillard L; Brugière P
    Sem Ther; 1964 Apr; 40(4):273. PubMed ID: 5878803
    [No Abstract]   [Full Text] [Related]  

  • 15. The biological half-life of I-131 fibrinogen.
    Hart HC
    Thromb Diath Haemorrh Suppl; 1965; 17():121-31. PubMed ID: 5006855
    [No Abstract]   [Full Text] [Related]  

  • 16. [Apopos of a new case of intolerance to contrast iodinated products rapidly jugulated by episilon-amino-caproic acid].
    Lawson P
    Sem Ther; 1967 Dec; 43(10):638. PubMed ID: 5589949
    [No Abstract]   [Full Text] [Related]  

  • 17. [Contribution of epsilon aminocaproic acid (Hemocaprol) to the treatment of functional uterine hemorrhages during the premenopausal period].
    Jamon G
    Therapeutique; 1972 Dec; 48(10):717-9. PubMed ID: 4661296
    [No Abstract]   [Full Text] [Related]  

  • 18. [Microanalysis of two antifibrinolytics (epsilon-aminocaproic acid and tranexamic acid) by liquid chromatography and fluorometry].
    Lacroix C; Levert P; Laine G; Goulle JP
    J Chromatogr; 1984 Jul; 309(1):183-6. PubMed ID: 6480765
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the use of an antifibrinolytic agent in otorhinolaryngology].
    Wayoff M
    Sem Ther; 1965 Feb; 41(2):108. PubMed ID: 5878681
    [No Abstract]   [Full Text] [Related]  

  • 20. Prolonged fibrinolytic prophylactic treatment with nicotinic acid derivatives and MAO-inhibitors.
    De Nicola P
    Thromb Diath Haemorrh Suppl; 1966; 20():289-95. PubMed ID: 5298378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.